NYSEAMERICAN:ASXC Asensus Surgical (ASXC) Stock Price, News & Analysis $0.35 0.00 (0.00%) (As of 08/22/2024) Add Compare Share Share Today's Range$0.35▼$0.3550-Day Range N/A52-Week Range$0.17▼$0.40VolumeN/AAverage Volume2.03 million shsMarket Capitalization$94.74 millionP/E RatioN/ADividend YieldN/APrice Target$0.35 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Asensus Surgical alerts: Email Address Asensus Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside0.6% Upside$0.35 Price TargetShort InterestHealthy4.23% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.24) to ($0.13) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.08 out of 5 stars 1.0 Analyst's Opinion Consensus RatingAsensus Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAsensus Surgical has received no research coverage in the past 90 days.Read more about Asensus Surgical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.23% of the float of Asensus Surgical has been sold short.Short Interest Ratio / Days to CoverAsensus Surgical has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Asensus Surgical has recently decreased by 12.41%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAsensus Surgical does not currently pay a dividend.Dividend GrowthAsensus Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASXC. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 5 people have searched for ASXC on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Asensus Surgical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.87% of the stock of Asensus Surgical is held by insiders.Percentage Held by InstitutionsOnly 9.35% of the stock of Asensus Surgical is held by institutions.Read more about Asensus Surgical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Asensus Surgical are expected to grow in the coming year, from ($0.24) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Asensus Surgical is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Asensus Surgical is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAsensus Surgical has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingExposed: The Plot to Destroy AmericaIs Your Family Prepared for Kamala’s America? The coup has already begun. Kamala Harris is just one step away from the presidency, and her plan will devastate every state in America. Find out how to shield your wealth and thrive in the coming chaos.Get the inside scoop and learn how to protect your savings. About Asensus Surgical Stock (NYSEAMERICAN:ASXC)Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.Read More ASXC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASXC Stock News HeadlinesAugust 22, 2024 | globenewswire.comAsensus Surgical Announces Closing of Acquisition by KARL STORZAugust 21, 2024 | bizjournals.comDurham public company staves off potential bankruptcy, will be acquiredSeptember 10, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.August 15, 2024 | bizjournals.comDurham company could face bankruptcy if $95M sale failsAugust 14, 2024 | msn.comBiggest stock movers today: NU, K, and moreAugust 13, 2024 | msn.comAsensus says it expects to file for bankruptcy if merger vote failsAugust 13, 2024 | seekingalpha.comAsensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | finance.yahoo.comAsensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024September 10, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.August 13, 2024 | markets.businessinsider.comAsensus Surgical is about to announce earnings — here's what Wall Street expectsAugust 8, 2024 | uk.finance.yahoo.comMenhaden Resource Efficiency PLC - Net Asset Value(s)August 8, 2024 | globenewswire.comAsensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024August 7, 2024 | globenewswire.comAsensus Surgical 2024 Special Meeting of Stockholders Is AdjournedJuly 30, 2024 | globenewswire.comIndependent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZJuly 29, 2024 | globenewswire.comGlass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZJuly 27, 2024 | bloomberg.comAsensus Bridges Digital to Surgery: Vanguards of Health CareJuly 24, 2024 | globenewswire.comAsensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery ProgramJuly 23, 2024 | finanznachrichten.deAsensus Surgical, Inc.: Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in UrologySee More Headlines Receive ASXC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:ASXC CUSIPN/A CIKN/A Webwww.asensus.com Phone(919) 765-8400Fax919-765-8459Employees170Year FoundedN/APrice Target and Rating Average Stock Price Target$0.35 High Stock Price Target$0.35 Low Stock Price Target$0.35 Potential Upside/Downside+0.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,430,000.00 Net Margins-902.25% Pretax Margin-899.16% Return on Equity-184.10% Return on Assets-114.75% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.69 Sales & Book Value Annual Sales$8.58 million Price / Sales11.04 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book2.68Miscellaneous Outstanding Shares272,330,000Free Float264,516,000Market Cap$94.74 million OptionableNot Optionable Beta1.37 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Anthony Fernando (Age 52)President, CEO & Director Comp: $901.03kMr. Shameze Rampertab B.Sc. MBA (Age 57)CA, CPA, Executive VP & CFO Comp: $511.25kMr. Joshua B. Weingard (Age 51)Chief Legal Officer & Secretary Mr. Paul Ziegler Jr. (Age 50)J.D., Vice President of Sales Mr. Ethan LoiselleVice President of Global MarketingMs. Amanda OwensVice President of PeopleMr. Ravi KommineniHead of Global Quality & RegulatoryMr. Motti FrimerVice President of R&D, Digital Solutions and MD of Asensus SurgicalMore ExecutivesKey CompetitorsWestaimOTCMKTS:WEDXFTreace Medical ConceptsNASDAQ:TMCINano-X ImagingNASDAQ:NNOXClearPoint NeuroNASDAQ:CLPTTactile Systems TechnologyNASDAQ:TCMDView All CompetitorsInsidersWilliam N Starling JrBought 18,134 shares on 12/14/2023Total: $5,077.52 ($0.28/share)View All Insider Transactions ASXC Stock Analysis - Frequently Asked Questions How have ASXC shares performed this year? Asensus Surgical's stock was trading at $0.2466 at the start of the year. Since then, ASXC shares have increased by 41.1% and is now trading at $0.3479. View the best growth stocks for 2024 here. How were Asensus Surgical's earnings last quarter? Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its earnings results on Tuesday, August, 13th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.02. The firm earned $2.21 million during the quarter, compared to analyst estimates of $1.30 million. Asensus Surgical had a negative net margin of 902.25% and a negative trailing twelve-month return on equity of 184.10%. Who are Asensus Surgical's major shareholders? Top institutional investors of Asensus Surgical include Concourse Financial Group Securities Inc.. Insiders that own company stock include Andrea Biffi, William N Starling Jr, David Bruce Milne and Elizabeth Kwo. View institutional ownership trends. How do I buy shares of Asensus Surgical? Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:ASXC) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredKamala’s Secret 3-Word Plan to Destroy America… Are You Prepared?America’s Slow Decline into Hell As Kamala Harris rises to power, her 3-word agenda threatens every America...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredMike Huckabee Puts His Faith in This to Protect His RetirementMike Huckabee's Urgent Warning: Safeguard Your Financial Future NowAmerican Hartford Gold Group | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asensus Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Asensus Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
